Human Evidence and Safety Human Studies: Only two very small pilot studies in humans exist (one for bladder pain, one for knee pain, each with fewer than 20 participants)7
Combining GHK-Cu with other peptides Many researchers use GHK-Cu alongside other peptides
Always consult with your oncologist if you have a history of malignancy before starting a peptide protocol
Clarifying these factors is essential for future trial design, the optimization of inclusion criteria, and the identification of the clinical phenotypes and healthcare settings most likely to benefit from GCSF therapy
On day 13, the animals were anaesthetized again as described above
What is not established: any benefit for intestinal permeability, leaky gut, IBS, or inflammatory bowel disease